nystatin-a1 has been researched along with Hypersensitivity* in 16 studies
2 trial(s) available for nystatin-a1 and Hypersensitivity
Article | Year |
---|---|
A controlled trial of nystatin for the candidiasis hypersensitivity syndrome.
Topics: Candidiasis; Candidiasis, Vulvovaginal; Female; Humans; Hypersensitivity; Nystatin; Research Design; Syndrome | 1991 |
A randomized, double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome.
Candida albicans infection has been proposed to cause a chronic hypersensitivity syndrome characterized by fatigue, premenstrual tension, gastrointestinal symptoms, and depression. Long-term antifungal therapy has been advocated as treatment for the syndrome, which is most often diagnosed in women with persistent or recurrent candida vaginitis.. To determine the efficacy of nystatin therapy for presumed candidiasis hypersensitivity syndrome, we conducted a 32-week randomized, double-blind, cross-over study using four different combinations of nystatin or placebo given orally or vaginally in 42 premenopausal women who met present criteria for the syndrome and had a history of candida vaginitis. The outcomes studied were the changes from base line in scores for vaginal, systemic, and overall symptoms and in the results of standardized psychological tests.. The three active-treatment regimens (oral and vaginal nystatin, oral nystatin and vaginal placebo, and oral placebo and vaginal nystatin) and the all-placebo regimen significantly reduced both vaginal and systemic symptoms (P less than 0.001), but nystatin did not reduce the systemic symptoms significantly more than placebo. On average, the scores for systemic symptoms improved 25 percent with the three active-treatment regimens and 23 percent with the all-placebo regimen, a difference of only 2 percent (95 percent confidence interval, -3 to 7 percent). As expected, the three active-treatment regimens were more effective than placebo in relieving vaginal symptoms (P less than 0.001). All four regimens reduced psychological symptoms and global indexes of distress; there were no significant differences among the treatment regimens.. In women with presumed candidiasis hypersensitivity syndrome, nystatin does not reduce systemic or psychological symptoms significantly more than placebo. Consequently, the empirical recommendation of long-term nystatin therapy for such women appears to be unwarranted. Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Capsules; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypersensitivity; Nystatin; Syndrome | 1990 |
14 other study(ies) available for nystatin-a1 and Hypersensitivity
Article | Year |
---|---|
The pathogenetic significance of intestinal Candida colonization.
Topics: Antifungal Agents; Candida; Candidiasis; Controlled Clinical Trials as Topic; Gastrointestinal Diseases; Humans; Hypersensitivity; Immunoglobulin E; Nystatin; Reproducibility of Results; Research Design; Syndrome | 2004 |
Searching for the yeast connection.
Topics: Candidiasis; Humans; Hypersensitivity; Nystatin; Syndrome | 1990 |
[Use of kenakort and kenacomb in the therapy of certain dermatoses].
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Drug Combinations; Female; Gramicidin; Humans; Hypersensitivity; Male; Middle Aged; Neomycin; Nystatin; Ointments; Skin Diseases; Triamcinolone Acetonide | 1974 |
[Chronic urticaria and Quincke's oedema. 100 case reports. Allergology and therapeutic results].
Topics: Adolescent; Adult; Aged; Allergens; Angioedema; Candida albicans; Candidiasis; Child; Chronic Disease; Desensitization, Immunologic; Female; Humans; Hypersensitivity; Male; Middle Aged; Nystatin; Urticaria | 1972 |
Acrodermatitis perstans. Generalization following therapy with nystatin.
Topics: Acrodermatitis; Adult; Candidiasis, Cutaneous; Chronic Disease; Humans; Hypersensitivity; Male; Middle Aged; Nystatin | 1971 |
An assessment of the role of Candida albicans and food yeasts in chronic urticaria.
Topics: Adult; Amphotericin B; Antigens; Candida; Candidiasis; Chronic Disease; Female; Food Hypersensitivity; Humans; Hypersensitivity; Immunoglobulin E; Male; Nystatin; Saccharomyces; Skin Tests; Urticaria | 1971 |
[Broncho-pulmonary mycoses].
Topics: Actinomycosis; Africa; Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Farmer's Lung; France; Histoplasmosis; Humans; Hypersensitivity; Lung Diseases, Fungal; Nystatin; Sputum; United States | 1969 |
The etiology, exfoliative cytology, and treatment of denture stomatitis.
Topics: Acrylic Resins; Adult; Aged; Anti-Bacterial Agents; Candidiasis, Oral; Chromium Alloys; Cytodiagnosis; Denture, Complete; Denture, Partial, Removable; Drug Resistance, Microbial; Female; Humans; Hypersensitivity; Male; Middle Aged; Nystatin; Palate; Stomatitis; Tissue Conditioning, Dental | 1969 |
[Allergic type of pulmonary aspergillosis].
Topics: Aspergillosis; Humans; Hypersensitivity; Immunoelectrophoresis; Lung Diseases, Fungal; Male; Middle Aged; Nystatin | 1969 |
Tetracycline and nystatin.
Topics: Candidiasis; Humans; Hypersensitivity; Nystatin; Tetracycline | 1969 |
ERYTHEMA ANNULARE CENTRIFUGUM DUE TO CANDIDA ALBICANS.
Topics: Candida albicans; Candidiasis; Drug Therapy; Erythema; Humans; Hypersensitivity; Hypersensitivity, Delayed; Nystatin; Skin Diseases, Genetic | 1965 |
[ALLERGIC REACTIONS TO ANTIBIOTICS: CASE CONSIDERATIONS AND SEROLOGICAL RESEARCH].
Topics: Anaphylaxis; Anti-Bacterial Agents; Chloramphenicol; Colistin; Diagnosis; Drug Hypersensitivity; Humans; Hypersensitivity; Nystatin; Penicillins; Statistics as Topic; Streptomycin; Tetracycline; Toxicology | 1964 |
CLINICAL LIMITATIONS OF EXPERIMENTAL CUTANEOUS MONILIASIS (CANDIDA ALBICANS).
Topics: Amphotericin B; Candida; Candida albicans; Candidiasis; Candidiasis, Cutaneous; Desensitization, Immunologic; Gentian Violet; Humans; Hypersensitivity; Nystatin | 1963 |
Combining antibiotic with antigen therapy in cases in T.O.E. (yeast and fungus) allergy.
Topics: Anti-Bacterial Agents; Fungi; Griseofulvin; Hypersensitivity; Mycoses; Nystatin | 1960 |